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Abstract
Multi-polypeptide proteins such as antibodies are difficult to express in prokaryotic systems such as E. coli due to the
complexity of protein folding plus secretion. Thus far, proprietary strains or fermenter cultures have been required for
appreciable yields. Previous studies have shown that expression of heterologous proteins in E. coli can be enhanced by the
reduction of protein translation rates. In this paper, we demonstrate that useful quantities of full-length IgG can be
expressed and purified from the common E. coli laboratory strain HB2151 in standard shaking culture using a simple
strategy of reduced inducer concentration combined with delayed induction times to modulate translation rates. Purified
IgG had only marginally reduced avidity compared to mammalian derived IgG. This indicates that this technique can be
used to derive antibodies of potentially equal utility as those expressed in mammalian cell culture, particularly for
applications where effector functions mediated by the glycosylated residues in the Fragment Crystallizable (Fc) portion of
the immunoglobulin are not required.
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Introduction
In the immune system and also for many therapeutic antibody
applications, the Fc region recruits receptors and cell types that
maintain the circulating half life of unbound antibodies. With
antibody-antigen interaction, the Fc region initiates the main
antibody effector functions: complement-dependent cytotoxicity
(CDC), antibody-dependent cellular cytotoxicity (ADCC), and
phagocytosis, which ultimately result in clearance of the antigen.
For many therapeutic applications, although retention of the
circulating half life of the antibody is crucial, recruitment of
effector functions is not necessary.
Traditionally, full-length antibodies have been expressed in
mammalian tissue culture, primarily because the motifs within the
Fc region responsible for effector ligand recruitment require the
presence of both specific amino acids as well as glycosylation
[1,2,3] Indeed, alteration of the glycoform can affect the affinity of
the Fc for various receptor domains and hence determine the
specific type of effector function activated [4,5,6,7]. In the case of
antibody circulating half life, the motif within the Fc region
responsible for receptor interaction is not dependant on glycosyl-
ation, and expression of aglycosylated antibodies does not affect
circulating half life [3,8].While production of aglycosylated
antibodies can be achieved in mammalian cell expression through
deletion of the glycosylation signal, recently, aglycosylated
antibodies have been produced via expression in E. coli [8,9].
However, removal of periplasmic proteases via molecular
engineering of the E.coli strain used, along with fermentation
culture, was required to achieve appreciable yield.
Antibodies are not ideal for expression in E. coli as they are
complicated multimeric proteins made from two different
polypeptides, the heavy (HC) and light chains (LC), which must
be exported into the periplasm, folded properly and form the
appropriate disulfide bonds. As such, considerable effort has been
made to optimize bacterial hosts for antibody and antibody
fragment expression. Engineering of oxidizing cellular environ-
ments, co-expression of molecular chaperones, use of periplasmic
protease deficient strain of E. coli and balancing of heavy and light
chain expression have all enabled increased yield of up to 1 mg/L
[8,10,11]. However, these options often require some degree of
further optimization such as balancing expression of each
polypeptide chain, or the use of proprietary modified E. coli strains
which are not readily available. Modification of translation
initiation regions (TIRs) to reduce protein translation rates has also
had some success at improving overall yield [12]. The lower
translation rate is believed to decrease protein load on the secretory
system, reducing the accumulation of unprocessed products in the
cytoplasm. Indeed, the highlevel expression of antibody obtained in
fermentor cultures was obtained using balanced but low strength
TIRs for both heavy and light chains [8].
In this study, we explored strategies for optimization of antibody
expression in general laboratory strains of E. coli using simple
methods for reducing translation rates. These include the use of a
low-copy number plasmid, reduction of inducer concentration and
induction of antibody HC/LC at late log phase. Single step
purification on Protein A resulted in co-elution of bacterial
proteins along with degraded heavy chain. Introduction of a
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contaminating proteins and heavy chain fragments.
Results
Preliminary bacterial IgG expression
For expression of full length IgG we constructed a bicistronic
expression cassette driven by a tetracycline inducible promoter
where the light chain contained an OmpA leader sequence and
the heavy chain contained a PelB leader sequence separated by an
intercistronic ribosomal binding site (Figure 1). Using standard
conditions, our initial attempts to produce full-length IgG in E. coli
resulted in undetectable yields of fully assembled IgG and only
unassembled or extensively degraded heavy chain fragments were
detected on immunoblot (data not shown). In order to reduce the
degradation of IgG, we utilized the E. coli strain commonly used
for protein expression, BL21(DE3), which is deficient in the
cellular proteases Lon and OmpT. Periplasmic extraction was also
employed rather than whole cell lysis, in the hope that only fully
assembled IgG would be extracted and not unprocessed heavy and
light chain. Analysis of the periplasmic extract after overnight
expression of a chimeric antibody termed 4G2, showed fully
assembled IgG with both HB2151 and BL21(DE3) (Figure 2A).
Surprisingly, reduction of the extracts to allow resolution of the
heavy and light chains revealed the presence of increased
degradation of the heavy chain with the protease deficient
BL21(DE3) compared to HB2151, suggesting that proteolysis of
the heavy chain is not due to Lon or OmpT proteases (Figure 2B).
Optimization of expression in small scale culture
Expression of full-length IgG, Fab as well as other proteins
appear to be significantly enhanced by reduction of protein
translation rates and ten-fold reduction in translation rates has
been shown to significantly increase secretion of heterologous
proteins in E. coli [12]. We therefore explored various methods for
reducing translation rates to investigate if this improved yield. A
simple method for adjusting these rates is to reduce inducer
concentrations and such modulation has been previously demon-
strated in similar tetracycline promoter based systems in other
bacterial hosts such as Mycobacteria as well as E. coli. [13,14]
Vectors that employ a tetracycline based promoter also enable
tight control of expression that is independent of the host strain or
metabolism [15], and dictated our initial construction of the
bacterial IgG cassette in this vector Previous experiments using the
Tet repressor had shown that below 50 ng/ml, concentration of
inducer becomes limiting although the relationship between
expression yield and inducer is not linear [13,14]. We therefore
carried out an induction at the manufacturer’s recommended
concentration of 200 ng/ml, and at 50 ng/ml and 20 ng/ml.
Other methods which can reduce translation rates include
induction of expression when the bacteria are approaching late log
phase. This was used previously by Mazor et al for the production
of full-length IgG [9]. Accordingly, aside from the standard OD600
0.6 for induction we also tested expression when induction was
started with culture at OD600 1.0. Use of low copy number
plasmids has also been shown to decrease translation rate [14]. In
the course of constructing our expression vector, we generated
both a low copy and high copy version of our expression plasmid,
by addition of a single base pair mutation in the origin of
replication. The difference in copy number between the high and
low copy plasmids, based on miniprep DNA yields, is estimated to
be approximately eight- to ten- fold.
To analyze expression induced by our new construct, we
employed five different full length IgGs. One was a chimeric
antibody derived from the anti-dengue mouse monoclonal
hybridoma 4G2; and the other four fully human antibodies
isolated from a naı ¨ve human phage display library; of which two
(ET21 and ET149) were raised against Clostridium perfringens epsilon
toxin and the other two (PA38 and PA64) against Bacillus anthracis
protective antigen. Studies were carried out in small scale shake
cultures with various combinations of different concentrations of
inducer, induction at different optical densities (OD) and using
either high or low copy expression vector, as indicated. In order to
prevent leakage of expressed antibody from the periplasm during
growth by mechanical sheer, which commonly occurs during
periplasmic expression in the HB2151 E. coli strain, protein
expression was carried out in non-baffled flasks at a slower shaking
speed of 120 rpm. Levels of fully assembled and functional IgG in
the clarified cell lysate were then determined by immunoblot,
standard induction conditions (200 ng/ml inducer, high copy
plasmid & induction at OD600 1.0) was also used as a comparison
between immunoblots, and direct binding ELISA respectively
(Figure 3).
Initial experiments indicated that variation of inducer concen-
tration resulted in significant differences in wet cell mass
(Figure 3F), which can have a significant influence on overall
yield. Therefore, to distinguish whether improved yield is due to
an increase in wet cell mass or an increase in levels of fully
Figure 1. Construction of tet promoter bacterial IgG expression plasmid. pASK-IBA2 plasmid using a tet promoter was used as the
backbone expression vector. The appropriate restriction sites for cloning in of the light and variable heavy chains, leader sequences (OmpA, PelB) and
the constant heavy chain sequence (CH) were added. Light (LC) and variable chains (VH) were cloned in as a complete construct together with the
intercistronic ribosomal binding site (RBS) from the phage display vector or as separate constructs from the 4G2 mammalian IgG expression vector.
doi:10.1371/journal.pone.0010261.g001
Figure 2. Initial bacterial IgG expression and periplasmic
extraction. (A and B) Non-reducing and reducing immunoblot of
periplasmic extract from overnight expression of 4G2 in HB2151 (HB)
and BL21(DE3) (BL) E. coli strains, respectively. All blots were probed
with anti-Human Fc-HRPO.
doi:10.1371/journal.pone.0010261.g002
IgG in Common E. coli
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harvesting and resuspended in a volume of lysis buffer adjusted for
wet cell mass thus ensuring that subsequently derived lysate
samples are from equivalent wet cell masses.
The levels of fully assembled and functional IgG as measured by
immunoblot and direct binding ELISA respectively correlate well
for all five antibodies expressed. In general, the strongest full sized
IgG band (<200 kDa) on the immunoblot and the highest signal
by ELISA were obtained when the same set of conditions were
used (Figure 3A-E). Furthermore, there was a significant increase
in wet cell mass when the lowest inducer concentration (20 ng/ml)
was used in conjunction with high copy plasmid with up to
approximately two-fold increase over the standard induction
conditions or other conditions with higher inducer concentrations
Figure 3. Small scale optimization of bacterial IgG expression. (A-E) Left and middle panels: Non-reducing immunoblot of 7.5 ml clarified cell
lysate from small scale overnight expression of bacterial IgG in shaking culture. All blots were probed with anti-Human Fc-HRPO and adjusted to
ensure equal intensity. Arrows indicate fully-assembled IgG. Right panel: Direct binding ELISA indicating levels of functional IgG. Background binding
signal was negligible for all cell lysate samples at the indicated dilution or neat. Error bars were calculated from average of three or four observations.
Expressed antibodies were 4G2 (A), PA38 (B), PA64 (C), ET21 (D), ET149 (E). (F) Variation in wet cell mass for all five antibodies under different
induction conditions. Mass is indicated in mg.
doi:10.1371/journal.pone.0010261.g003
IgG in Common E. coli
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cell mass was observed over standard induction conditions, which
was unaffected by changing induction OD and inducer concen-
tration. These effects were observed for all five antibodies tested
and consistently the largest wet cell mass yield was observed with
the combination of high copy plasmid, 20 ng/ml inducer
concentration and induction at OD600 1.0. However, this
combination did not always give the best unit yield.
For chimeric 4G2 and PA64, this set of conditions was indeed
the best as indicated by both immunoblot and ELISA, although
for 4G2 induction with 20 ng/ml inducer at OD600 0.6 showed a
larger full sized IgG band by immunoblot; however the ELISA
signal did not increase (Figure 3A & C). For PA38 any inducer
concentration in combination with high copy plasmid and
induction at OD600 1.0 gave the highest yields (Figure 3B). In
contrast, for ET21 and ET149 the highest unit yields were
obtained using the higher inducer concentrations of 200 ng/ml or
50 ng/ml in combination with a high copy plasmid and induction
at OD600 1.0 (Figure 3D & E). Interestingly, when low copy
plasmid was used, unit yields were less affected by variation of OD
or inducer concentration (Figure 3A-E). In general, with the
exception of ET149, use of low copy plasmids gave equivalent or
better unit yields over standard induction conditions (200 ng/ml
inducer at OD600 0.6); however the optimized conditions with the
high copy number plasmid always showed the greatest unit yield.
Degradation was observed to some extent for all five antibodies
although the smaller sized degradation fragment bands were
fainter than the full sized bands, indicating that it was not a
significant problem overall (Figure 3A-E).
Comparison of yield by larger scale expression
Based on the analysis of cell lysate from the small scale
expression of five antibodies, we have determined that best
expression levels can be obtained using only two sets of conditions:
for PA38, PA64 and 4G2, optimal expression was observed from
the high copy plasmid, induced at OD600 1.0 with 20 ng/ml
inducer. The yield would also be enhanced further by the greater
wet cell mass obtained under this condition. For ET21 and
ET149, 50 ng/ml inducer appears to be optimal in comparison to
20 ng/ml (with high copy plasmid and induction at OD600 1.0)
but due to the reduced wet cell mass overall yield might not be
better. In order to determine which of the two combinations above
gave the best overall yield, a larger scale expression was carried out
with a representative antibody which showed optimal expression
with each of the two combinations; 4G2 for 20 ng/ml inducer and
ET149 for 50 ng/ml inducer.
Purification was carried out on a 1 ml Protein A HPLC column
and elution of IgG was tracked using absorbance at 280 nm.
However, analysis of the individual peak fractions by SDS-PAGE
revealed the presence of multiple protein bands (Figure 4A & B).
Analysis of selected fractions by immunoblot (Figure 4B) revealed
that some of these protein bands were not antibody heavy or light
chains as they were not detected with antibodies against either
human Fc or kappa light chain. This indicated that they are more
likely to be bacterial proteins that co-purified with the bacterial
expressed IgG. The non-specific elution of bacterial proteins was
unexpected, as previous papers had reported clean elution of
bacterially expressed full-length IgG from Protein A [8,9]. The
decoration of protein bands between the heavy and light chain on
the reducing immunoblot indicates possible degradation of the
heavy chain (Figure 4B).
Due to the impurity of the Protein A eluate, it was decided to
carry out an additional purification step using Protein L, which
binds the antibody kappa light chain. Sequential purification first
on Protein A followed by Protein L enabled isolation of antibodies
that contain both heavy and light chain, thus eliminating any
unpaired heavy or light chain along with degraded fragments and
contaminating bacterial proteins (Figure 4B).
Comparison of overall yields from 1.6L of culture by
quantitation of total protein in pooled Protein L eluate from the
two different conditions after sequential protein A and protein L
purification indicated that as expected, expression of 4G2 at
OD600 1.0 using an inducer concentration of 20 ng/ml and high
copy plasmid resulted in yields with approximately two-fold
improvement (12.6 mg vs. 6.15 mg). However, for ET149 a change
of inducer concentration to 50 ng/ml gave only slightly improved
yields (6.3 mg vs. 6.15 mg), demonstrating the compensating effect
of greater wet cell mass at 20 ng/ml inducer concentration.
Comparison of bacterially expressed IgG with
mammalian expressed IgG
Following removal of the bacterial contaminant proteins and
heavy chain degradation products through protein L purification
we next analyzed the presence of fully assembled tetrameric IgG.
Analysis of the protein L eluate on non-reducing SDS-PAGE
indicated that a large proportion of the purified chimeric 4G2 and
ET149 IgG was present as fully assembled IgG (Figure 5A).
However partially assembled IgG representing 2HC-1LC and
1HC-1LC was also evident. The increase of partially assembled
IgG seen with expression in E. coli could be due to inefficient
disulfide bond formation during assembly within the bacterial
periplasm.
To determine whether the bacterially expressed IgG retained
the same binding avidity as those expressed in mammalian cell
culture, an ELISA of serially diluted purified IgG expressed from
both bacterial and mammalian cell cultures was carried out
against Dengue-2 and epsilon toxin using 4G2 and ET149
respectively. A slight decrease in avidity was observed for both
4G2 and ET149 bacterially expressed IgG in comparison to
mammalian cell culture derived IgG (Figure 5B). This could be
due to an increased percentage of partially assembled IgG in the
bacterially expressed antibodies as observed in the SDS-PAGE
gels (Figure 5A). The partially assembled IgGs would have reduced
avidity as there was only one antigen binding site present.
Discussion
From our initial experiments, it was clear that IgG expression in
E. coli laboratory strains using general expression protocols gave
poor yields and highly degraded product and the use of the
protease-deficient BL21 strain was unable to reduce degradation.
Previous studies suggested that overload of the secretory system
was responsible for the poor yield and we therefore undertook
optimization of expression conditions to minimize load via
reduction of translational levels. We have demonstrated in this
paper on the basis of expression of five different antibodies that
reduction of translational levels by using reduced inducer
concentrations in combination with delayed induction improved
yields of full-length IgG by both increasing the yield of wet cell
mass, as well as in certain antibodies the unit yield (yield per unit
wet cell mass), over standard induction conditions. This effect was
observed only when high copy plasmids were used.
Interestingly, the effect of varying inducer concentration and
induction OD on wet cell mass and unit yields was minimal when
low copy plasmids were used. It may be that the low copy number
results in a low baseline translation level which is not further
reduced by induction OD or inducer concentration. While it does
give a modest improvement in wet cell mass and in some
IgG in Common E. coli
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conditions, we have found that generally the optimized high copy
plasmid conditions perform better in terms of wet cell mass and
unit yields. Whereas a later induction at higher OD appears to
either have no effect or a mild positive effect on unit yields when
high copy plasmids were used, particularly for PA38, PA64 or
4G2. Interestingly, for ET21 and ET149, it may be that these
antibodies are stable enough to be properly folded even at higher
translation rates and therefore reducing translation rates through
induction at higher OD or reducing inducer concentration has no
or a negative effect on unit yields. In particular, expression from
the high copy plasmid induced at OD600 1.0 with 20 ng/ml
inducer, demonstrated optimal antibody yield for all antibodies
tested either through direct increase of unit yield or through the
increased cell number provided by the higher wet cell mass.
Purification of the cell lysate with Protein A was insufficient to
give pure full-length IgG with bacterial proteins and heavy chain
fragments co-purifying in the eluate and as a result subsequent
Protein L purification was required. The inability of Protein A
purification alone to give purified antibody, in contrast to
previously reported findings, could be due to the extremely low
yield of IgG resulting in non-specific binding of bacterial proteins
to unoccupied Protein A binding sites. However, due to the large
volume of lysate required to be processed for reasonable antibody
yields, a sufficiently large Protein A column must be used for
efficient antibody capture and hence having empty binding sites is
an unavoidable consequence of the low yield of fully assembled
IgG. Furthermore, this step is also required for the removal of the
heavy chain degradation fragments.
The ability of our bacterial IgGs to bind both Protein A and
Protein L indicates that the binding sites on the antibody are
presented on the surface and suggests that the IgG is properly
folded. Crucially, the purified 4G2 and ET149 antibodies were
able to bind their respective antigens albeit with slightly reduced
avidity as compared to mammalian cell expressed antibody and
indicates that bacterially expressed IgG could substitute for
mammalian derived IgG. E. coli expressed IgG1 has been found
to bind the neonatal Fc receptor (FcRn) and have the same
pharmacokinetic parameters in the circulatory system as mam-
malian cell expressed IgG2 and IgG4b, but was unable to bind
complement (C1q) or FccRI [8]. This suggests that E. coli derived
antibodies lack effector functions as expected for aglycosylated
antibodies. The inability of aglycosylated antibodies to bind Fcc
receptors has also been demonstrated in mammalian derived
aglycosylated antibodies [16]. In addition, as reduction of
translational levels appears to be beneficial to periplasmic
Figure 4. Large scale purification of bacterial IgG. (A) Non-reducing coomassie gel of peak fractions from Protein A HPLC purification of cell
lysate. Left panel: 4G2 fractions 5 to 11 (F5 to F11). Right panel ET149 fractions 10 to 16 (F10 to F16). 30 ml of each fraction was run on the gel. A
sample of the wash (LW) was run and shows no contaminants present indicating the column was sufficiently washed to remove non-binding
proteins. Fully assembled IgGs (2H2L) are indicated. (B). Reducing coomassie gels (4G2-F7, ET149-F12 & 13) and adjacent immunoblots (I) showing
representative fractions from each Protein A elution (indicated with * on panel A). 30 ml of each fraction was loaded for coomassie and 3.75 ml for
immunoblot. Blots were probed with both anti-IgG Fc and anti-Kappa chain polyclonals showing that majority of protein bands in the fraction are
neither IgG heavy chain nor light chain. A separate reducing coomassie gel shows 2 mg of bacterial IgG pooled eluate (EL) after Protein L purification
showing successful removal of the contaminating proteins and degraded heavy chain fragments. The equivalent amount of mammalian cell culture-
derived IgG (IgG) was loaded for comparison. Individual heavy (HC) and light (LC) chains are indicated although the light chain for ET149 appears as
two separate species.
doi:10.1371/journal.pone.0010261.g004
IgG in Common E. coli
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prove to be useful for improving the yields of other periplasmically
expressed proteins.
Materials and Methods
Plasmid construction
The backbone of the expression plasmid was derived from
pASK-IBA2 (IBA GmbH, Germany), which contains a tetracy-
cline based promoter and an OmpA leader sequence for export
into the periplasm. Onto this a bicistronic expression cassette was
constructed where the light chain, the intercistronic ribosomal
binding site, and the heavy chain variable region with the PelB
leader sequence was cloned in as a complete construct from the
phage display library via ApaL1 and BsmB1 cloning sites. The
heavy chain constant region of human G1 was cloned in
previously to be in frame with the variable heavy region. During
the course of plasmid construction, deletion of a backbone
restriction enzyme site situated within the origin of replication
had created a reduced copy number plasmid in addition to the
normal high copy number plasmid. For generation of the
humanized 4G2 construct, the light chain and variable heavy
chains was cloned in as separate constructs via ApaL1/AscI and
Mfe/Xho1 restriction sites respectively. The four fully human
antibodies were isolated by standard panning protocols against the
respective purified antigen with the naı ¨ve human phage display
library HX01 (Humanyx Pte Ltd, Singapore), and cloned into the
bacterial IgG expression vector using ApaL1 and BsmB1.
Optimization of expression with BL21(DE3)
The low copy number 4G2 expression plasmid was transformed
into either HB2151 or BL21(DE3) E. coli and grown up in 2YT
broth with 100 mg/ml carbenicillin. Induction was carried out at
OD600 1.0 with 1/10 normal inducer concentration (final
concentration of 20 ng/ml). Periplasmic extraction was carried
out by resuspending the pellet in 1/40 volume chilled periplasmic
extraction buffer (100 mM Tris pH 8.0, 150 mM NaCl, 1 mM
EDTA, 0.5 M sucrose, 1 mM PMSF, 1 mg/ml pepstatin A,
10 mM iodoacetamide), sonicating briefly on ice and then gently
rotated at 10 rpm for 1 hr at 4uC. Cells were collected at 40000 g
for 30 min at 4uC and the supernatant was retained.
Small scale optimization of bacterial IgG expression
conditions
Expression plasmids were transformed into E. coli strain
HB2151 and grown up as a starter culture. 50 ml of 2YT broth
with 100 mg/ml carbenicillin was inoculated with 1/50 volume of
starter culture and grown at 30uC at 220 rpm. Induction was
carried out as indicated and cultures transferred to room
temperature and grown overnight at 120 rpm. The bacterial
pellet was weighed and resuspended in chilled lysis buffer (20 mM
Figure 5. Comparison between bacterial and mammalian IgG. (A). Non-reducing SDS-PAGE of 2 mg of pooled bacterial IgG eluate after
protein L purification (EL) and mammalian cell culture-derived IgG (IgG) indicates that the majority of purified IgG was fully assembled IgG (2H2L)
although partially assembled IgG (2H1L, 1H1L) are also present. (B). Direct binding ELISA of serially diluted bacterial (-&-)- and mammalian cell culture
(-N-)-derived IgG against Dengue serotype-2 virus and epsilon toxin showing similar binding curves. Binding of antibody was detected using anti-
Human IgG Fc-HRPO as the secondary antibody.
doi:10.1371/journal.pone.0010261.g005
IgG in Common E. coli
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0.5 mM PMSF, 1 mg/ml pepstatin A, 10 mM iodoacetamide
and Roche Complete protease inhibitor) at a ratio of 1 ml per
200 mg wet cell mass and sonicated on ice. Lysates were clarified
by centrifugation at 16000 g for 30 min at 4uC. All cultures were
grown up in non-baffled shake flasks and cytoplasmic extraction
carried out as described above for all subsequent experiments.
Large-scale expression and purification of bacterial IgG
Expression of 4G2 was carried out in 26800 mL of 2YT media
with 100 mg/ml carbenicillin in 2 L non-baffled shake flasks as
described above with the following optimized conditions: high
expression construct was used and induction was carried out at
OD600 1.0 using 20 ng/ml or 50 ng/ml final inducer concentra-
tion. The cell pellet was weighed and resuspended in lysis buffer at
the same volume to wet cell mass ratio as above, sonicated and
clarified by centrifugation at 20000 g for 30 min at 4uC. The cell
lysate was passed through a 0.22 mm filter before purification on a
1 ml recombinant Protein A FF column (GE Healthcare, United
Kingdom) fitted to a AKTAprime Plus or Explorer FPLC system
(GE Healthcare, United Kingdom). Lysate was passed through the
column at a flow rate of 0.5 ml/min, then the column washed with
30 ml 16PBS before elution in 0.5 ml fractions with IgG elution
buffer (Pierce, United States). Fractions were neutralized with 1/
10 volume 1 M Tris pH 8.0. Peak fractions were pooled and buffer
exchanged into 2 ml Protein L binding buffer (100 mM sodium
phosphate buffer pH 7.2, 150 mM NaCl) with a Amicon 30000
MWCO concentrator (Millipore, United States) and then bound
to 400 ml Protein L agarose bead 50% slurry (Pierce, United
States) overnight at 4uC. The beads were washed with ten column
volumes of 16 PBS in column and IgG eluted with IgG elution
buffer (Pierce, United States) and neutralized as above. Eluate was
buffer exchanged into 16 PBS/20% glycerol and concentrated
down to 150 ml volume.
Immunoblot & Protein quantitation
Samples taken during extraction and purification were
resolved by SDS-PAGE with or without DTT and transblotted
to a Hybond-C nitrocellulose membrane (GE Healthcare,
United Kingdom). IgG was detected using HRPO labeled
polyclonal anti-human Fc antibody (Roche, Switzerland) diluted
1:2500 in 16PBS with 0.05% Tween-20 and 5% skim milk or
in combination with anti-human Kappa antibody (Roche,
Switzerland) in the above diluent at 1:5000 dilution each. Blots
were washed eight times with 16 PBS with 0.05% Tween-20
and once with 16 PBS and then signal developed with
SuperSignal West Pico Substrate (Pierce, United States).
Samples with and without DTT were run on 10% and 8%
SDS-polyacrylamide gels respectively. To measure protein
concentration, 30 ml of Protein L purified IgG eluate was
diluted in 16 PBS to 150 ml and measured by the Bradford
method using the Coomassie Plus kit (Pierce, United States)
according to manufacturer’s protocol,
Mammalian cell culture IgG expression and ELISA
Full-length 4G2 or ET149 IgG1 antibody was transiently
expressed in 293T suspension culture. The antibody heavy and
light chains were cloned into a biscistronic pCMV vector and
transfected into cells using 293fectin (Invitrogen, United States)
according to manufacturer’s protocols. Expressed antibody was
recovered from the culture supernatant and purified on Protein A
(Pierce, United States).
ELISA was carried out by coating a Maxisorb 96-well ELISA
plate (Nunc, Denmark) with 20 mg/ml of protein antigen or 50 ml
of live DEN-2 virus (strain ST) in 16PBS. For protein antigens,
the plate was then washed twice with 16 PBS and blocked with
360 ml of blocking solution (4% skim milk in 16PBS) for 2 hrs at
room temperature. For dengue ELISAs virus was captured using
mouse 4G2 monoclonal coated at 5 mg/ml and blocked as above
prior to the addition of virus. Virus was allowed to bind for 1 hr at
room temperature and excess virus removed with two washes with
16PBS/0.05% Tween-20.
100 ml of antibody (diluted at a 1:2 ratio from 5 mg/ml to
0.076 mg/ml) or clarified cell lysate (at dilutions from 1:2 to 1:64)
was then added in blocking solution for 1 hr followed by
secondary antibody, HRPO labeled polyclonal anti-human IgG
Fc antibody (Roche, Switzerland) at 1:5000 dilution, also in
blocking solution, for another 1 hr. TMB (Pierce, United States)
was added to develop color and stopped with 2 M sulfuric acid. All
steps except the blocking step were carried out in 100 ml volumes
and at room temperature except for ELISAs involving dengue
virus which were done at 50 ml volumes. The ELISA plate was
washed four times with 16PBS/0.05% Tween-20 between each
step after blocking except prior to addition of TMB in which the
last wash was with 16PBS instead. For ELISAs involving dengue
virus only two 16PBS/0.05% Tween-20 washes were carried out
except for the last prior to addition of TMB where an additional
16PBS wash was done.
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